474 related articles for article (PubMed ID: 15795415)
21. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
22. Contralateral prophylactic mastectomy: quantifying benefits and weighing the harms.
Helzlsouer KJ
J Clin Oncol; 2005 Jul; 23(19):4251-3. PubMed ID: 15795414
[No Abstract] [Full Text] [Related]
23. Contralateral prophylactic mastectomy.
Rai SS; Mahabir RC; Roberts JW; Song J; Hamid KS; White RR
Ann Plast Surg; 2011 Sep; 67(3):215-9. PubMed ID: 21508813
[TBL] [Abstract][Full Text] [Related]
24. Mortality impact of less-than-standard therapy in older breast cancer patients.
Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
[TBL] [Abstract][Full Text] [Related]
25. Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002.
Yao K; Winchester DJ; Czechura T; Huo D
Breast Cancer Res Treat; 2013 Dec; 142(3):465-76. PubMed ID: 24218052
[TBL] [Abstract][Full Text] [Related]
26. The effects of radiotherapy for the treatment of contralateral breast cancer.
Schootman M; Jeffe DB; Gillanders WE; Yan Y; Aft R
Breast Cancer Res Treat; 2007 May; 103(1):77-83. PubMed ID: 17033921
[TBL] [Abstract][Full Text] [Related]
27. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
Isern AE; Tengrup I; Loman N; Olsson H; Ringberg A
J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1177-87. PubMed ID: 17938010
[TBL] [Abstract][Full Text] [Related]
28. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program.
Macdonald OK; Lee CM; Tward JD; Chappel CD; Gaffney DK
Cancer; 2006 Nov; 107(9):2127-33. PubMed ID: 16998937
[TBL] [Abstract][Full Text] [Related]
29. Recurrence in breast cancer. Analysis with frailty model.
Gohari MR; Mahmoudi M; Mohammed K; Pasha E; Khodabakhshi R
Saudi Med J; 2006 Aug; 27(8):1187-93. PubMed ID: 16883450
[TBL] [Abstract][Full Text] [Related]
30. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
[TBL] [Abstract][Full Text] [Related]
31. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
[TBL] [Abstract][Full Text] [Related]
32. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
[TBL] [Abstract][Full Text] [Related]
33. Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival.
Mery CM; George S; Bertagnolli MM; Raut CP
Cancer; 2009 Sep; 115(18):4055-63. PubMed ID: 19526590
[TBL] [Abstract][Full Text] [Related]
34. Increasing rates of contralateral prophylactic mastectomy - a trend made in USA?
Güth U; Myrick ME; Viehl CT; Weber WP; Lardi AM; Schmid SM
Eur J Surg Oncol; 2012 Apr; 38(4):296-301. PubMed ID: 22305274
[TBL] [Abstract][Full Text] [Related]
35. Survival analysis of contralateral prophylactic mastectomy: a question of selection bias.
Kruper L; Kauffmann RM; Smith DD; Nelson RA
Ann Surg Oncol; 2014 Oct; 21(11):3448-56. PubMed ID: 25047478
[TBL] [Abstract][Full Text] [Related]
36. [Follow-up of breast cancer: review of 750 cases after 5 years].
Martínez-Regueira F; Díez-Caballero A; Sierra A; Espí A; Baixauli J; Zornoza A
Rev Med Univ Navarra; 1998; 42(1):7-13. PubMed ID: 10420951
[TBL] [Abstract][Full Text] [Related]
37. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
[TBL] [Abstract][Full Text] [Related]
38. Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.
Alkner S; Bendahl PO; Fernö M; Nordenskjöld B; Rydén L;
Eur J Cancer; 2009 Sep; 45(14):2496-502. PubMed ID: 19535242
[TBL] [Abstract][Full Text] [Related]
39. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.
Tuttle TM; Habermann EB; Grund EH; Morris TJ; Virnig BA
J Clin Oncol; 2007 Nov; 25(33):5203-9. PubMed ID: 17954711
[TBL] [Abstract][Full Text] [Related]
40. Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base.
Pesce CE; Liederbach E; Czechura T; Winchester DJ; Yao K
J Am Coll Surg; 2014 Jul; 219(1):19-28. PubMed ID: 24862886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
